| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 05/17/2006 | CN1772736A Separation process of extracting high-purity 3-picoline from picoline mixture |
| 05/17/2006 | CN1772380A Catalyst for gas-solid phase synthesis of 2-chloro-5-trichloro methyl pyridine and its prepn |
| 05/17/2006 | CN1256324C Pyrrolidine derivatives as factor Xa inhibitors |
| 05/16/2006 | US7045660 [di(ether or thioether)heteroaryl or fluoro substituted aryl] compound or an N-oxide thereof or a salt thereof, useful for inhibiting the production or physiological effects of TNF in treatment of a patient suffering from a disease state associated with a detrimental excess of tumor necrosis factor |
| 05/16/2006 | US7045653 Pharmaceuticals |
| 05/16/2006 | US7045649 compounds are suitable, for example, for use as anorectics |
| 05/16/2006 | US7045636 MCH antagonists for the treatment of obesity |
| 05/16/2006 | US7045632 Composition and method for a hexadentate ligand and bimetallic complex for polymerization of olefins |
| 05/16/2006 | US7045631 Substituted 2-thio-3, 5-dicyano-4-phenyl-6-aminopyridines and their use as adenosine receptor-selective ligands |
| 05/16/2006 | US7045551 such as (R)-N-[2-hydroxy-1-(3-morpholin-4-yl-phenyl)-ethyl]-3-phenyl-propionamide; for treatment of migraines, bipolar disorders, epilepsy, acute/chronic pain and anxiety |
| 05/16/2006 | US7045541 Compounds for the treatment of metabolic disorders |
| 05/16/2006 | US7045538 Neurotransmitter moderator; analgesics; using n-methyl-5-(5-methoxy-3-pyridyl)-4-penten-2-amine |
| 05/16/2006 | US7045536 Compound having anti-viral activity |
| 05/16/2006 | US7045532 ACE-2 modulating compounds and methods of use thereof |
| 05/16/2006 | US7045519 Pyrimidine or pyridine derivatives |
| 05/16/2006 | US7045512 Controlling fungi in plants, seeds |
| 05/16/2006 | US7044987 6-alkoxy-2,3-diaminopyridine couplers in which the amino radical in position 2 is a monosubstituted amino radical, and use of these couplers for dyeing keratin fibres |
| 05/16/2006 | CA2242571C Amino compounds and angiotensin iv receptor agonists |
| 05/11/2006 | WO2006050480A2 Substituted pyridines with activity on syk kinase |
| 05/11/2006 | WO2006050264A1 Cationic ceramides, and analogs thereof, and their use for preventing or treating cancer |
| 05/11/2006 | WO2006050097A1 Substituted phenylalkanoic acids |
| 05/11/2006 | WO2006048331A1 11β-HSD1 INHIBITORS |
| 05/11/2006 | WO2006048251A1 Anthranilamide pyridinureas as vegf receptor kinase inhibitors |
| 05/11/2006 | WO2006048172A1 Process for preparation of isonicotinic acid derivatives |
| 05/11/2006 | WO2005051317A3 Substituted imidazo ring systems and methods |
| 05/11/2006 | WO2005009965A8 Nicotinamide derivatives useful as pde4 inhibitors |
| 05/11/2006 | US20060100456 Diastereoselective method of preparing olefins by means of the horner-wadsworthemmons reaction, comprising the addition of a tris-(polyoxaalkyl)-amine sequestering agent |
| 05/11/2006 | US20060100441 Process for the preparation of 2-aminomethylpyridine derivative |
| 05/11/2006 | US20060100440 Process for the preparation of isonicotinic acid derivatives |
| 05/11/2006 | US20060100439 Process for the preparation of modification I of n-(1-methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridinesulfonamide |
| 05/11/2006 | US20060100289 Nitrone compounds, pharmaceutical compositions containing the same and methods for treating inflammation and neuropathic pain |
| 05/11/2006 | US20060100252 Beta 3 adrenergic receptor agonists; pollakiuria or urinary incontinence; antiulcer, overactive bladder, pancreatitis, obesity, diabetes, insulin resistance, hypertriglyceridemia, hypercholesterolemia, tocolytic agents; 4'-[2-(2-hydroxy-2-phenylethyl]amino]ethyl]-4-biphenylyl]acetic acid |
| 05/11/2006 | US20060100251 Substituted phenylalkanoic acids |
| 05/11/2006 | US20060100250 Biphenyl derivatives and their use as fungicides |
| 05/11/2006 | US20060100249 Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses |
| 05/11/2006 | US20060100246 Synthesis of I kappa B kinase beta inhibitors that are 2-amino-4,6-disubstituted nicotinic acid ester analogs, by reacting an aryl ketone, an aldehyde and a cyanoacetate with an ammonium salt |
| 05/11/2006 | US20060100245 Substituted biphenyl-4-carboxylic acid arylamide analogues |
| 05/11/2006 | US20060100225 Heteroaryl guanidines; inhibitors of viral replication |
| 05/11/2006 | US20060100217 Preparation of 4-haloalkylnicotinamides |
| 05/11/2006 | US20060100192 Heteroaryl diazacycloalkanes, their preparation and use |
| 05/11/2006 | US20060100123 Use of metal complex compounds as oxidation catalysts |
| 05/11/2006 | US20060100106 Phenyl-substituted 2-enamino-ketonitriles |
| 05/11/2006 | DE4338348B4 2,6-Disubstituierte Benzotrifluoride 2,6-Disubstituted benzotrifluorides |
| 05/11/2006 | CA2586931A1 Process for preparation of isonicotinic acid derivatives |
| 05/11/2006 | CA2586271A1 Anthranilamide pyridinureas as vascular endothelial growth factor (vegf)receptor kinase inhibitors |
| 05/11/2006 | CA2585775A1 Cationic ceramides, and analogs thereof, and their use for preventing or treating cancer |
| 05/11/2006 | CA2585615A1 Dicarboxamide derivatives and their use as factor xa inhibitors |
| 05/11/2006 | CA2585555A1 Substituted phenylalkanoic acids |
| 05/11/2006 | CA2584808A1 Substituted pyridines with activity on syk kinase |
| 05/10/2006 | EP1655295A1 Anthranilamide pyridinureas as VEGF receptor kinase inhibitors |
| 05/10/2006 | EP1655286A1 Process for producing low-melting crystal of free disopyramide base |
| 05/10/2006 | EP1654260A2 6-menbered heteroaryl compounds for the treatment of neurodegenerative disorders |
| 05/10/2006 | EP1654247A1 Alkynyl aryl carboxamides |
| 05/10/2006 | EP1654238A1 2-aminopyrimidine and 2-aminopyridine-4-carbamates for use in the treatment of autoimmune diseases |
| 05/10/2006 | EP1654235A1 3- aminocarbonyl, 6-phenyl substituted pyridine-1-oxides as p38 kinase inhibitors |
| 05/10/2006 | EP1654234A1 Nicotinamide derivatives useful as pde4 inhibitors |
| 05/10/2006 | EP1654233A2 Method for the manufacture of cyanopyridines and catalysts suitable therefor |
| 05/10/2006 | EP1654232A1 Sulfonyl substituted n-(biarylmethyl) aminocyclopropanecarboxamides |
| 05/10/2006 | EP1654231A2 Compositions and methods for reducing the risk of epileptic occurrence and/or for treatment of seizure disorders |
| 05/10/2006 | EP1654225A2 Melanin concentrating hormone receptor antagonists |
| 05/10/2006 | EP1654220A1 Compounds for modulating cell proliferation |
| 05/10/2006 | EP1359892B1 Primary intermediates for oxidative coloration of hair |
| 05/10/2006 | EP1358179B1 Synthesis method and intermediates of pyridin-2-yl-methylamine |
| 05/10/2006 | EP1254159B1 Process for the preparation of acetyl-amidiniophenylalanyl-cyclohexylglycyl-pyridylalaninamides |
| 05/10/2006 | EP1208186B1 Composition and method for bleaching a substrate |
| 05/10/2006 | CN1771229A Process for the preparation of pyridinyl and pyrimidinyl mono-fluorinated beta keto-esters |
| 05/10/2006 | CN1771087A Method for preparing bisphenol catalysts and bisphenols |
| 05/10/2006 | CN1771084A Ti-pillared clay based vandia catalyst and process for preparation |
| 05/10/2006 | CN1769270A Catalyst componemt ligand precursor, ligand compound for ethene polymerization and oligopolymerization |
| 05/10/2006 | CN1255419C Ligands and catalyst systems thereof for ethylene oligomerisation to produce linear alpha olefins |
| 05/10/2006 | CN1255404C Process for preparing substituted imidazopyridine compound |
| 05/10/2006 | CN1255365C Fluorene compound and organic lumnescent device using the same |
| 05/09/2006 | US7041856 Reacting an unsaturated organic compound and boron compound using coupling catalyst comprising a nickel compound and a nitrogen-containing cyclic compound |
| 05/09/2006 | US7041691 E.g., 2-(2,6-Dichloro-4-nitro-phenylsulfanyl)-benzothiazole-5-carboxylic acid methyl ester; modulators of peroxisome proliferator-activated receptors (PPARs) to treat type 11 diabetes and obesity; hypertension, hyperlipidemia, hypercholesterolemia, and hyperlipoproteinemia; antiinflammatory agents |
| 05/09/2006 | US7041670 Florfenicol-type antibiotics |
| 05/09/2006 | US7041659 Compounds for the treatment of metabolic disorders |
| 05/09/2006 | US7041390 group 9 or 10 metal complexes of N-(N-heterocycle-substuted)acridines, phenoxazines and phenothiazines that are capable of converting a triplet excitation state into light emission and excellent in heat resistance; electronic devices with low power consumption |
| 05/09/2006 | CA2322501C Processes for the preparation of (r)-.alpha.-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol |
| 05/04/2006 | WO2006047302A1 Bissulfonamide compounds as agonists of galr1, compositions, and methods of use |
| 05/04/2006 | WO2006046916A1 Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases |
| 05/04/2006 | WO2006046914A1 Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases |
| 05/04/2006 | WO2006046778A1 3-carbamoyl-2-pyridone derivative |
| 05/04/2006 | WO2006046774A1 Use of a pyridine compound for the preparation of a medicament for the treatment of skin lesions |
| 05/04/2006 | WO2006046593A1 Benzene compound having 2 or more substituents |
| 05/04/2006 | WO2006046508A1 Ruthenium complex and process for producing tert-alkyl alcohol therewith |
| 05/04/2006 | WO2006046131A1 Tetralin histamine-3 receptor antagonists |
| 05/04/2006 | WO2006045514A1 3-arylamino pyridine derivatives |
| 05/04/2006 | WO2006045204A1 Aryl sulfonic pyridoxines as antiplatelet agents |
| 05/04/2006 | WO2006045203A1 Substituted pyridoxines as anti-platelet agents |
| 05/04/2006 | WO2006012227A3 Amido compounds and their use as pharmaceuticals |
| 05/04/2006 | WO2005105718A3 Process for the production of cyclic diketones |
| 05/04/2006 | WO2005100353A8 Condensed pyridine derivatives useful as a28 adenosine receptor antagonists |
| 05/04/2006 | US20060094902 Amino acid analogues |
| 05/04/2006 | US20060094882 Ambient-temperature molten salts and process for producing the same |
| 05/04/2006 | US20060094875 Platinum complexes |
| 05/04/2006 | US20060094789 Alpha- and beta-amino acid hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors |
| 05/04/2006 | US20060094769 e.g. methyl 4-{[(5-ethoxy-5-oxopentyl)(2-methoxyphenethyl)amino]methyl}benzoate; stimulant of guanylate cyclase; catalyse the biosynthesis of cGMP from guanosine triphosphate (GTP); cardiovascular disorders; liver fibrosis |
| 05/04/2006 | US20060094761 such as 4-{4-fluoromethyl-2-methyl-5-[(4-carbamimidoyl-benzyloxy)-methyl]-pyridin-3-yloxymethyl}-benzamidine, that inhibit the proteases of the blood and thus block platelet aggregation, used for the treatment of cardiovascular disorders |
| 05/04/2006 | US20060094749 Substituted pyridoxines as anti-platelet agents |
| 05/04/2006 | US20060094748 Aryl sulfonic pyridoxines as antiplatelet agents |